$2.39
3.24% yesterday
NYSE, Sep 27, 10:10 pm CET
ISIN
US67080N1019
Symbol
NUVB
Sector
Industry

Nuvation Bio Inc - Ordinary Shares - Class A Stock price

$2.39
-0.69 22.40% 1M
-1.58 39.80% 6M
+0.88 58.28% YTD
+0.99 70.71% 1Y
-7.40 75.59% 3Y
-7.61 76.10% 5Y
-7.61 76.10% 10Y
NYSE, Closing price Fri, Sep 27 2024
-0.08 3.24%
ISIN
US67080N1019
Symbol
NUVB
Sector
Industry

Key metrics

Market capitalization $615.64m
Enterprise Value $328.09m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 227.84
P/S ratio (TTM) P/S ratio 427.53
P/B ratio (TTM) P/B ratio 2.39
Revenue (TTM) Revenue $1.44m
EBIT (operating result TTM) EBIT $-112.68m
Free Cash Flow (TTM) Free Cash Flow $-84.27m
Cash position $577.17m
EPS (TTM) EPS $-2.11
P/E forward negative
P/S forward 437.56
EV/Sales forward 233.18
Short interest 11.78%
Show more

Is Nuvation Bio Inc - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Nuvation Bio Inc - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast:

5x Buy
100%

Analyst Opinions

5 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast:

Buy
100%

Financial data from Nuvation Bio Inc - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
1.44 1.44
-
100%
- Direct Costs 1.76 1.76
340% 340%
122%
-0.32 -0.32
20% 20%
-22%
- Selling and Administrative Expenses 36 36
20% 20%
2,497%
- Research and Development Expense 76 76
1% 1%
5,278%
-112 -112
6% 6%
-7,797%
- Depreciation and Amortization 0.41 0.41
3% 3%
28%
EBIT (Operating Income) EBIT -113 -113
6% 6%
-7,825%
Net Profit -511 -511
465% 465%
-35,467%

In millions USD.

Don't miss a Thing! We will send you all news about Nuvation Bio Inc - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nuvation Bio Inc - Ordinary Shares - Class A Stock News

Neutral
Business Wire
14 days ago
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced positive pooled data from the pivotal Phase 2 TRUST-I and TRUST-II studies evaluating taletrectinib, an investigational next-generation ROS1 TKI. The findings will be highlighted in a poster presentation on Sept...
Neutral
Business Wire
19 days ago
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio, will present at the Cantor Global Healthcare Conference in New York, NY on Thursday, September 19, 2024, at 9:45 a.m. E.T. ...
Neutral
Business Wire
2 months ago
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced multiple updates for its taletrectinib program. Data from the global, pivotal Phase 2 TRUST-II study has been accepted for an oral presentation at WCLC 2024 taking place September 7-10 in San Diego, California. ...
More Nuvation Bio Inc - Ordinary Shares - Class A News

Company Profile

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Head office United States
CEO David Hung
Employees 51
Founded 2018
Website www.nuvationbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today